Entry of elemental arsenic into the central nervous system in patients with acute promyelocytic leukemia during arsenic trioxide treatment

Leuk Res. 2008 Feb;32(2):357-8. doi: 10.1016/j.leukres.2007.06.005. Epub 2007 Jul 26.
No abstract available

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Arsenic / cerebrospinal fluid*
  • Arsenic Trioxide
  • Arsenicals / adverse effects*
  • Central Nervous System / chemistry*
  • Humans
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Oxides / adverse effects*

Substances

  • Antineoplastic Agents
  • Arsenicals
  • Oxides
  • Arsenic
  • Arsenic Trioxide